Lyra Therapeutics (LYRA) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts LYRA Hot Sheet
Join SI Premium – FREE
Lyra Therapeutics (NASDAQ: LYRA) reported Q2 EPS of ($0.36), $0.06 better than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Lyra Therapeutics (LYRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kodiak Gas Services, Inc. (KGS) Reports Q2 EPS of $0.55
- BRC Group (RILY) Reports Q2 EPS of $0.45
- Phio Pharmaceuticals Corp. (PHIO) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
